Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Learn how to identify crypto coins to hold long term based on fundamentals, use cases, and risk tolerance. Build a resilient, diversified portfolio with smart criteria.
28,040 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Nike looks undervalued here may be more than a short-term swing. This article breaks down why patient investors could...
Fox Factory's Q4 2025 results shed light on demand for high-performance suspensions and the company’s margin discipli...
Geopolitical tensions and volatile oil prices have investors hunting for stock-wue winners beyond crude. Here are two...
Two healthcare ETFs offer very different paths for investors: a broad, low-cost core and a concentrated pharmaceutica...
Facing market volatility, savvy investors turn to durable brands. Here are two consumer staples stocks right now that...
A bond market roar is sending a clear message to stock market investors urgent: yields are rising, and that can press...
Inflation trends keep shifting, and the fed's latest inflation forecast is a key signal for investors. This guide bre...
As SpaceX readiness enters the Russell 1000 framework, investors ask if the Vanguard VONG ETF belongs in a growth por...
Income-focused investors are turning to a small group of high-yield energy names that offer cash-flow visibility and ...
Two very different tech plays collide in 2026: Innodata edges into AI data preparation, while Workiva anchors large e...
Federal Realty Trust just raised its dividend for the 58th time, signaling steady income for investors. Learn how to ...